Kopran Ltd

Kopran Ltd

₹ 259 -1.67%
26 Feb - close price
About

Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide.

The export percentage is about 65% of the total sales.

Key Points

API Vertical (57%) [1]
Development, manufacturing, and sale of diverse Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. One of the leaders in Atenolol & one of the major players in Sterile Carbapenems. Their main products are Sterile Carbapenems (36%), Anti-Hypertensive (17%), and Macrolides (~16%). API vertical is operated by WOS Kopran Research Laboratories. [2] [3]

  • Market Cap 1,251 Cr.
  • Current Price 259
  • High / Low 292 / 96.0
  • Stock P/E 50.4
  • Book Value 81.3
  • Dividend Yield 1.16 %
  • ROCE 9.44 %
  • ROE 8.07 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 45.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 74.9%

Cons

  • Stock is trading at 3.19 times its book value
  • Company has a low return on equity of 7.08% over last 3 years.
  • Earnings include an other income of Rs.10.6 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
56.56 61.96 29.22 56.22 54.57 64.50 71.18 53.62 67.96 80.23 65.86 98.64 82.33
51.26 54.90 28.70 51.61 51.11 57.82 64.69 47.72 61.86 72.86 65.04 89.94 70.27
Operating Profit 5.30 7.06 0.52 4.61 3.46 6.68 6.49 5.90 6.10 7.37 0.82 8.70 12.06
OPM % 9.37% 11.39% 1.78% 8.20% 6.34% 10.36% 9.12% 11.00% 8.98% 9.19% 1.25% 8.82% 14.65%
2.52 2.23 2.35 1.97 1.58 2.28 0.17 14.74 1.16 2.07 1.48 5.79 1.29
Interest 0.70 0.54 0.65 0.53 0.98 0.80 0.50 0.61 0.72 0.84 0.95 0.74 1.02
Depreciation 1.05 1.05 1.08 1.09 1.10 1.06 1.08 1.12 1.12 1.09 1.12 1.16 1.17
Profit before tax 6.07 7.70 1.14 4.96 2.96 7.10 5.08 18.91 5.42 7.51 0.23 12.59 11.16
Tax % 28.67% 26.88% 23.68% 23.79% 21.62% 32.82% 25.20% 5.39% 25.46% 26.50% 30.43% 15.25% 23.75%
4.33 5.64 0.87 3.78 2.32 4.77 3.80 17.89 4.04 5.52 0.15 10.66 8.51
EPS in Rs 1.00 1.30 0.20 0.87 0.54 0.99 0.79 3.71 0.84 1.14 0.03 2.21 1.77
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
199 250 302 326 187 182 154 197 179 223 205 273 327
177 216 264 294 162 164 145 174 156 193 189 245 298
Operating Profit 22 34 38 32 25 17 9 23 23 30 15 28 29
OPM % 11% 14% 13% 10% 13% 10% 6% 12% 13% 14% 8% 10% 9%
6 2 6 6 -0 9 8 3 2 10 8 16 11
Interest 10 12 14 13 10 10 7 5 6 4 3 3 4
Depreciation 11 12 12 10 3 3 3 3 3 4 4 4 5
Profit before tax 6 12 17 15 11 13 7 17 16 33 16 37 31
Tax % 0% 0% 0% 0% 0% 36% 32% 25% 29% 28% 27% 15%
6 12 17 15 11 8 5 13 11 23 12 31 25
EPS in Rs 1.58 3.09 4.36 3.77 2.64 1.97 1.09 3.00 2.59 5.43 2.44 6.48 5.15
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 55% 123% 46%
Compounded Sales Growth
10 Years: 1%
5 Years: 12%
3 Years: 15%
TTM: 27%
Compounded Profit Growth
10 Years: 10%
5 Years: 45%
3 Years: 41%
TTM: -19%
Stock Price CAGR
10 Years: 27%
5 Years: 48%
3 Years: 29%
1 Year: 135%
Return on Equity
10 Years: 7%
5 Years: 7%
3 Years: 7%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 39 39 39 41 43 43 43 43 43 43 48 48 48
Reserves 68 80 98 122 145 158 162 175 186 204 331 347 344
Preference Capital 9 9 9 9 9 0 9 6 0 0 0 0
103 102 129 38 33 56 44 44 46 16 37 28 32
69 71 64 74 57 54 51 56 52 61 48 82 108
Total Liabilities 279 293 329 275 279 311 300 319 327 324 464 506 532
112 106 103 33 35 39 38 42 43 47 46 47 55
CWIP 0 1 1 0 0 4 8 7 7 3 3 4 0
Investments 7 7 7 46 156 157 157 158 158 159 259 260 260
161 179 219 195 88 110 97 112 119 115 155 195 216
Total Assets 279 293 329 275 279 311 300 319 327 324 464 506 532

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
35 14 2 53 19 4 12 12 10 49 -38 17
-10 -8 -9 -10 -4 -9 -2 -4 1 -9 -100 10
-19 -12 7 -43 -15 5 -11 -7 -11 -40 138 -26
Net Cash Flow 6 -7 0 -0 0 -0 -0 -0 0 0 -0 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 69 72 66 33 38 77 48 83 86 81 106 112
Inventory Days 101 87 104 24 90 84 119 78 149 73 119 98
Days Payable 120 111 69 63 114 120 115 101 114 106 85 128
Cash Conversion Cycle 50 48 100 -6 14 41 52 60 121 48 139 82
Working Capital Days 60 76 110 145 54 89 105 94 114 86 192 150
ROCE % 7% 11% 11% 12% 10% 10% 5% 9% 8% 14% 6% 9%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
43.78% 43.78% 43.78% 43.78% 44.25% 44.25% 44.25% 44.29% 44.29% 44.49% 44.49% 44.49%
0.00% 0.16% 0.27% 0.75% 0.53% 0.50% 0.51% 0.34% 0.41% 0.34% 0.39% 0.48%
2.29% 0.69% 0.46% 0.16% 0.14% 0.13% 0.14% 0.14% 0.14% 0.14% 0.35% 0.14%
53.93% 55.37% 55.50% 55.31% 55.07% 55.11% 55.09% 55.22% 55.15% 55.03% 54.78% 54.88%
No. of Shareholders 35,83340,51238,19537,82239,90640,88341,76842,03441,56744,03853,79151,636

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents